PEDEVCO Earnings Calls
| Release date | May 14, 2026 |
| EPS estimate | $0.620 |
| EPS actual | $0.720 |
| EPS Surprise | 16.13% |
| Revenue estimate | 37.65M |
| Revenue actual | 40.222M |
| Revenue Surprise | 6.83% |
| Release date | Mar 31, 2026 |
| EPS estimate | -$0.200 |
| EPS actual | -$1.85 |
| EPS Surprise | -825.00% |
| Revenue estimate | 14.7M |
| Revenue actual | 23.082M |
| Revenue Surprise | 57.02% |
| Release date | Nov 14, 2025 |
| EPS estimate | -$0.0460 |
| EPS actual | -$0.0705 |
| EPS Surprise | -53.33% |
| Revenue estimate | 7.617M |
| Revenue actual | 6.961M |
| Revenue Surprise | -8.61% |
| Release date | Aug 14, 2025 |
| EPS estimate | $0.300 |
| EPS actual | -$0.0200 |
| EPS Surprise | -106.67% |
| Revenue estimate | 9.706M |
| Revenue actual | 6.972M |
| Revenue Surprise | -28.16% |
Last 4 Quarters for PEDEVCO
Below you can see how PED performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 14, 2025 |
| Price on release | $12.40 |
| EPS estimate | $0.300 |
| EPS actual | -$0.0200 |
| EPS surprise | -106.67% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $12.40 |
| Aug 11, 2025 | $12.22 |
| Aug 12, 2025 | $12.40 |
| Aug 13, 2025 | $12.37 |
| Aug 14, 2025 | $12.40 |
| Aug 15, 2025 | $11.98 |
| Aug 18, 2025 | $11.75 |
| Aug 19, 2025 | $11.60 |
| Aug 20, 2025 | $11.88 |
| 4 days before | 0.0161% |
| 4 days after | -4.19% |
| On release day | -3.35% |
| Change in period | -4.18% |
| Release date | Nov 14, 2025 |
| Price on release | $11.50 |
| EPS estimate | -$0.0460 |
| EPS actual | -$0.0705 |
| EPS surprise | -53.33% |
| Date | Price |
|---|---|
| Nov 10, 2025 | $11.85 |
| Nov 11, 2025 | $11.58 |
| Nov 12, 2025 | $12.15 |
| Nov 13, 2025 | $11.61 |
| Nov 14, 2025 | $11.50 |
| Nov 17, 2025 | $11.50 |
| Nov 18, 2025 | $10.80 |
| Nov 19, 2025 | $10.15 |
| Nov 20, 2025 | $10.28 |
| 4 days before | -2.95% |
| 4 days after | -10.59% |
| On release day | 0% |
| Change in period | -13.23% |
| Release date | Mar 31, 2026 |
| Price on release | $16.00 |
| EPS estimate | -$0.200 |
| EPS actual | -$1.85 |
| EPS surprise | -825.00% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $14.59 |
| Mar 26, 2026 | $15.15 |
| Mar 27, 2026 | $17.32 |
| Mar 30, 2026 | $16.67 |
| Mar 31, 2026 | $16.00 |
| Apr 01, 2026 | $16.25 |
| Apr 02, 2026 | $16.62 |
| Apr 06, 2026 | $16.30 |
| Apr 07, 2026 | $17.52 |
| 4 days before | 9.66% |
| 4 days after | 9.50% |
| On release day | 1.56% |
| Change in period | 20.08% |
| Release date | May 14, 2026 |
| Price on release | $14.86 |
| EPS estimate | $0.620 |
| EPS actual | $0.720 |
| EPS surprise | 16.13% |
| Date | Price |
|---|---|
| May 08, 2026 | $13.98 |
| May 11, 2026 | $14.03 |
| May 12, 2026 | $14.81 |
| May 13, 2026 | $13.93 |
| May 14, 2026 | $14.86 |
| May 15, 2026 | $15.50 |
| May 18, 2026 | $15.25 |
| May 19, 2026 | $15.39 |
| May 20, 2026 | $15.12 |
| 4 days before | 6.29% |
| 4 days after | 1.75% |
| On release day | 4.31% |
| Change in period | 8.15% |
PEDEVCO Earnings Call Transcript Summary of Q1 2026
PEDEVCO reported strong operational and financial performance in Q1 2026 as the combined company following the Juniper merger. Production averaged 8,091 BOE/d, revenue was $40.2 million and adjusted EBITDA was $21.5 million (a 404% increase vs. Q1 2025). The reported GAAP net loss of $25.6 million was driven largely by a $31.3 million net loss on derivative contracts, of which $27.9 million was a noncash mark-to-market adjustment. Working capital (excluding derivative-related items) improved materially from a $34.1 million deficit at year-end to a $7.0 million deficit at March 31. Net debt was approximately $87 million, with ~$33 million total liquidity and ~$22 million undrawn on the revolver. Management reiterated full‑year guidance of 6,500–7,000 BOE/d and $60–70 million of adjusted EBITDA with $16–20 million of net capex. Operational priorities include completing one high‑WI DUC in the D-J (expected online mid‑summer/early Q3), advancing Powder River technical evaluation, and a $10–13 million 2026 optimization program (pump conversions, interventions) expected to drive LOE improvements that build into 2027. Management emphasized capital discipline—no deployment ahead of return thresholds—and a hedge program designed to reduce cash‑flow volatility while allowing some upside participation.
Sign In
Buy PED